CY1108839T1 - Φαρμακευτικοι συνδυασμοι μελοξικαμης, φωσφορικης κωδεϊνης και παρακεταμολης - Google Patents
Φαρμακευτικοι συνδυασμοι μελοξικαμης, φωσφορικης κωδεϊνης και παρακεταμοληςInfo
- Publication number
- CY1108839T1 CY1108839T1 CY20091100239T CY091100239T CY1108839T1 CY 1108839 T1 CY1108839 T1 CY 1108839T1 CY 20091100239 T CY20091100239 T CY 20091100239T CY 091100239 T CY091100239 T CY 091100239T CY 1108839 T1 CY1108839 T1 CY 1108839T1
- Authority
- CY
- Cyprus
- Prior art keywords
- meloxicam
- pharmaceutically acceptable
- paraketamol
- phosphorine
- code
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001929 meloxicam Drugs 0.000 title abstract 2
- UNQNIRQQBJCMQR-UHFFFAOYSA-N phosphorine Chemical compound C1=CC=PC=C1 UNQNIRQQBJCMQR-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 208000002193 Pain Diseases 0.000 abstract 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000004454 Hyperalgesia Diseases 0.000 abstract 1
- 208000035154 Hyperesthesia Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- 229940111134 coxibs Drugs 0.000 abstract 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 229940127240 opiate Drugs 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200201395 | 2002-02-19 | ||
| EP03706774A EP1478366B1 (en) | 2002-02-19 | 2003-02-14 | Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108839T1 true CY1108839T1 (el) | 2014-07-02 |
Family
ID=27758232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100239T CY1108839T1 (el) | 2002-02-19 | 2009-02-27 | Φαρμακευτικοι συνδυασμοι μελοξικαμης, φωσφορικης κωδεϊνης και παρακεταμολης |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050090517A1 (enExample) |
| EP (2) | EP2050453B1 (enExample) |
| JP (1) | JP2005519936A (enExample) |
| CN (1) | CN100418533C (enExample) |
| AP (1) | AP1862A (enExample) |
| AT (2) | ATE415971T1 (enExample) |
| AU (1) | AU2003208485B2 (enExample) |
| CA (1) | CA2476939C (enExample) |
| CY (1) | CY1108839T1 (enExample) |
| DE (1) | DE60325020D1 (enExample) |
| DK (1) | DK1478366T3 (enExample) |
| EG (1) | EG24845A (enExample) |
| ES (2) | ES2318113T3 (enExample) |
| IL (2) | IL163637A0 (enExample) |
| NZ (1) | NZ535500A (enExample) |
| OA (1) | OA12778A (enExample) |
| PT (2) | PT1478366E (enExample) |
| SI (1) | SI1478366T1 (enExample) |
| WO (1) | WO2003070251A1 (enExample) |
| ZA (1) | ZA200407485B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005094832A1 (en) * | 2004-04-01 | 2005-10-13 | Boehringer Ingelheim International Gmbh | Compositions comprising meloxicam |
| WO2005117895A2 (en) * | 2004-06-04 | 2005-12-15 | Boehringer Ingelheim International Gmbh | Compositions comprising meloxicam |
| ITMI20060983A1 (it) * | 2006-05-18 | 2007-11-19 | Formevet S P A | Composizioni farmaceutiche veterinarie per il trattamento del dolore e dell'inifiamazione |
| WO2007138466A2 (en) * | 2006-06-01 | 2007-12-06 | Wockhardt Ltd | Pharmaceutical compositions comprising meloxicam and tramadol combination |
| US20080031950A1 (en) * | 2007-04-27 | 2008-02-07 | Nectid Inc. | Novel anelgesic combination |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
| EP2177215A1 (en) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of tramadol and NSAIDs |
| EP2311446A1 (en) | 2009-10-16 | 2011-04-20 | Laboratorios Del. Dr. Esteve, S.A. | Compositions comprising Tramadol and Celecoxib in the treatment of pain |
| IT1398321B1 (it) * | 2010-02-26 | 2013-02-22 | Formevet Spa Ora Formevet Srl | Associazione tra un analgesico ad azione centrale e un antinfiammatorio inibitore selettivo della cicloossigenasi 2 per il trattamento dell'infiammazione e del dolore in campo veterinario |
| EP2392319A1 (en) * | 2010-06-04 | 2011-12-07 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical compositions of co-crystals of tramadol and coxibs |
| WO2015004505A1 (es) * | 2013-07-11 | 2015-01-15 | More Pharma Corporation, S. De R.L. De C.V. | Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio |
| WO2019130049A1 (en) | 2017-12-29 | 2019-07-04 | Grünenthal GmbH | Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain |
| US20210346328A1 (en) * | 2018-09-21 | 2021-11-11 | The Johns Hopkins University | Compositions and methods for treating metabolic disorders |
| CN115300515A (zh) * | 2022-08-11 | 2022-11-08 | 南京红地生物科技有限公司 | 一种含有美洛昔康和盐酸曲马多的长效注射液 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA845785B (en) * | 1983-06-10 | 1985-03-27 | Adcock Ingram Lab Ltd | Pharmaceutical unit |
| ZA893422B (en) * | 1988-02-24 | 1991-01-30 | Adcock Ingram Lab Ltd | Pharmaceutical composition |
| WO1997020551A1 (en) * | 1995-12-05 | 1997-06-12 | Adcock Ingram Limited | Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
| FR2770131A1 (fr) * | 1997-10-27 | 1999-04-30 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
| TR200001942T2 (tr) * | 1997-12-22 | 2000-11-21 | Euro-Celtique, S.A. | Opioid agonist/antagonist kombinasyonlar |
| US6375957B1 (en) * | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| EP1289558A2 (en) * | 2000-05-31 | 2003-03-12 | Warner-Lambert Company Llc | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| CN100588395C (zh) * | 2000-06-13 | 2010-02-10 | Wyeth公司 | 含有环氧化酶-2抑制剂的止痛和抗炎药物 |
-
2003
- 2003-02-14 PT PT03706774T patent/PT1478366E/pt unknown
- 2003-02-14 AT AT03706774T patent/ATE415971T1/de active
- 2003-02-14 EP EP08170195A patent/EP2050453B1/en not_active Expired - Lifetime
- 2003-02-14 US US10/505,291 patent/US20050090517A1/en not_active Abandoned
- 2003-02-14 WO PCT/IB2003/000500 patent/WO2003070251A1/en not_active Ceased
- 2003-02-14 ES ES03706774T patent/ES2318113T3/es not_active Expired - Lifetime
- 2003-02-14 IL IL16363703A patent/IL163637A0/xx unknown
- 2003-02-14 ES ES08170195T patent/ES2376500T3/es not_active Expired - Lifetime
- 2003-02-14 AU AU2003208485A patent/AU2003208485B2/en not_active Ceased
- 2003-02-14 CA CA2476939A patent/CA2476939C/en not_active Expired - Lifetime
- 2003-02-14 OA OA1200400220A patent/OA12778A/en unknown
- 2003-02-14 PT PT08170195T patent/PT2050453E/pt unknown
- 2003-02-14 AP APAP/P/2004/003134A patent/AP1862A/en active
- 2003-02-14 JP JP2003569207A patent/JP2005519936A/ja active Pending
- 2003-02-14 DE DE60325020T patent/DE60325020D1/de not_active Expired - Lifetime
- 2003-02-14 EP EP03706774A patent/EP1478366B1/en not_active Expired - Lifetime
- 2003-02-14 AT AT08170195T patent/ATE524186T1/de not_active IP Right Cessation
- 2003-02-14 NZ NZ535500A patent/NZ535500A/en not_active IP Right Cessation
- 2003-02-14 CN CNB038085321A patent/CN100418533C/zh not_active Expired - Fee Related
- 2003-02-14 SI SI200331530T patent/SI1478366T1/sl unknown
- 2003-02-14 DK DK03706774T patent/DK1478366T3/da active
-
2004
- 2004-08-19 EG EGNA2004000074 patent/EG24845A/xx active
- 2004-08-19 IL IL163637A patent/IL163637A/en active IP Right Grant
- 2004-09-17 ZA ZA2004/07485A patent/ZA200407485B/en unknown
-
2009
- 2009-02-27 CY CY20091100239T patent/CY1108839T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1478366T3 (da) | 2009-03-30 |
| NZ535500A (en) | 2006-09-29 |
| OA12778A (en) | 2006-07-06 |
| JP2005519936A (ja) | 2005-07-07 |
| AP2004003134A0 (en) | 2004-09-30 |
| ES2376500T3 (es) | 2012-03-14 |
| DE60325020D1 (de) | 2009-01-15 |
| IL163637A (en) | 2010-11-30 |
| WO2003070251A1 (en) | 2003-08-28 |
| EP1478366B1 (en) | 2008-12-03 |
| SI1478366T1 (sl) | 2009-06-30 |
| ATE524186T1 (de) | 2011-09-15 |
| ES2318113T3 (es) | 2009-05-01 |
| AU2003208485B2 (en) | 2009-05-28 |
| CA2476939C (en) | 2012-08-28 |
| AU2003208485A1 (en) | 2003-09-09 |
| CA2476939A1 (en) | 2003-08-28 |
| AP1862A (en) | 2008-07-07 |
| CN1646133A (zh) | 2005-07-27 |
| ATE415971T1 (de) | 2008-12-15 |
| PT2050453E (pt) | 2012-01-03 |
| US20050090517A1 (en) | 2005-04-28 |
| EP2050453B1 (en) | 2011-09-14 |
| CN100418533C (zh) | 2008-09-17 |
| EP2050453A1 (en) | 2009-04-22 |
| EP1478366A1 (en) | 2004-11-24 |
| EG24845A (en) | 2010-10-21 |
| ZA200407485B (en) | 2005-12-28 |
| IL163637A0 (en) | 2005-12-18 |
| PT1478366E (pt) | 2009-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401169A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
| CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
| DK0657458T3 (da) | Inhibitorer af proteinkinase-C | |
| CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
| NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
| CY1112687T1 (el) | Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες | |
| MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
| NO20005224D0 (no) | BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse | |
| NO20052524L (no) | Aminerte isofiavonoidderivater og anvendelse derav | |
| DE69725825D1 (de) | 5-HT1F-Agonisten | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| SE0202598D0 (sv) | Alpha-7 Nicotinic receptor agonists and statins in combination | |
| DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
| CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
| SE0004053D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| AP1862A (en) | Pharmaceutical combinations of COX-2 inhibitors and opiates | |
| DE602004024393D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
| SE0102858D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| DE60208404D1 (de) | Kreuzverquerte glycopeptid-cephalosporin-antibiotika | |
| SE0003476D0 (sv) | Compounds | |
| CY1109496T1 (el) | Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| CY1105235T1 (el) | Συνθεσεις λασοφοξιφενης | |
| DK0916670T3 (da) | Pyrrolo[3,2-b]pyridiner og deres anvendelse som 5-HT1f-agonister |